1,5-Naphthyridine azolinone
US7268231B2 · kind B2 · utility
0Cited by
0References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 5, 2005 |
| Grant date | Sep 11, 2007 |
| Priority date | — |
| Expiry date | Dec 27, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
1,5-Naphthyridine azolinone derivatives are disclosed. These compounds are inhibitors of CDK1 and are useful as antiproliferative agents, such as anti-cancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.